Ovid Therapeutics Inc.
OVID
$1.56
-$0.01-0.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.16M | -4.68M | -10.24M | -9.25M | -14.01M |
| Total Depreciation and Amortization | 16.00K | 99.00K | 141.00K | 160.00K | 169.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 961.00K | 1.06M | 1.12M | -62.00K | 575.00K |
| Change in Net Operating Assets | -1.69M | -1.24M | -1.30M | -853.00K | -1.75M |
| Cash from Operations | -12.87M | -4.77M | -10.28M | -10.01M | -15.01M |
| Capital Expenditure | -- | -- | -- | -22.00K | 4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.05M | 12.05M | 5.10M | 21.31M | 288.00K |
| Cash from Investing | 5.05M | 12.05M | 5.10M | 21.29M | 292.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15.00K | 0.00 | 13.00K | 0.00 | 38.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.00K | 0.00 | 13.00K | 0.00 | 38.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.80M | 7.28M | -5.17M | 11.28M | -14.68M |